Filing Details

Accession Number:
0001140361-17-004974
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-08 08:20:44
Reporting Period:
2017-02-06
Filing Date:
2017-02-08
Accepted Time:
2017-02-08 08:20:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1128189 Protokinetix Inc. PKTX Pharmaceutical Preparations (2834) 943355026
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516077 Edward Clarence Smith 1845 Country Road #214
St. Augustine FL 32084
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-06 750,000 $0.04 53,820,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,946,626 Indirect See Footnote
Common Stock 1,850,000 Indirect See Footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Option $0.05 2020-12-31 5,000,000 5,000,000 Direct
Common Stock Option $0.08 2019-12-31 5,000,000 5,000,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-12-31 5,000,000 5,000,000 Direct
2019-12-31 5,000,000 5,000,000 Direct
Footnotes
  1. Shares held by the Clarence E. Smith Trust.
  2. Shares held in the reporting person's retirement account.
  3. Options granted pursuant to 2015 Stock Option and Stock Bonus Plan. On March 31, 2016, 1,250,000 shares vest; thereafter 1,250,000 vest each quarter.
  4. Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On March 31, 2017, 1,250,000 shares vest; thereafter 1,250,000 vest each quarter.